Risk of macular degeneration with statin use should be interpreted with caution

BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7324.1308a (Published 01 December 2001) Cite this as: BMJ 2001;323:1308
  1. Redmer van Leeuwen, PhD student, department of epidemiology and biostatistics,
  2. Johannes R Vingerling, ophthalmologist, department of ophthalmology,
  3. Paulus T V M de Jong, professor, department of epidemiology and biostatistics
  1. Erasmus Medical Centre, NL-3000 DR Rotterdam, Netherlands

    EDITOR—Hall et al in their study suggest a remarkable protective effect of cholesterol lowering statins on age related macular degeneration.1 Defined as the end stage of age related maculopathy according to an international classification and grading system,2 age related macular degeneration is a common, blinding disease in elderly people, and treatment options are limited. The economic potential of new drugs for this disease would be huge, and, if confirmed by other studies, the …

    View Full Text

    Sign in

    Log in through your institution